共 50 条
- [31] The rarity of antinuclear antibody negativity in systemic lupus erythematosus: comment on the article by Merrill et al ARTHRITIS AND RHEUMATISM, 2011, 63 (04): : 1157 - 1158
- [32] Pertinence of cardiovascular disease risk awareness in adolescent patients with systemic lupus erythematosus: comment on the article by Scalzi et al ARTHRITIS AND RHEUMATISM, 2008, 58 (12): : 3971 - 3972
- [33] Increased levels of interleukin-18 in patients with systemic lupus erythematosus: comment on the article by Shibatomi et al - Reply ARTHRITIS AND RHEUMATISM, 2002, 46 (05): : 1411 - 1412
- [35] New evidence for the role of interferon regulatory factor 5 in the development of systemic lupus erythematosus: comment on the article by Tada et al ARTHRITIS AND RHEUMATISM, 2011, 63 (08): : 2543 - 2543
- [36] New evidence for the role of proteasome inhibitors in systemic lupus erythematosus: comment on the article by Ichikawa et al ARTHRITIS AND RHEUMATISM, 2012, 64 (04): : 1302 - 1302
- [38] DNASE I mutation and systemic lupus erythematosus in a Spanish population:: comment on the article by Tew et al ARTHRITIS AND RHEUMATISM, 2002, 46 (07): : 1974 - 1976
- [39] The rarity of antinuclear antibody negativity in systemic lupus erythematosus: comment on the article by Merrill et al Reply ARTHRITIS AND RHEUMATISM, 2011, 63 (04): : 1158 - 1158